Diversified Trust’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Buy
+370
New +$217K ﹤0.01% 933
2026
Q1
– Sell
-406
Closed -$228K – 1103
2025
Q4
$228K Buy
406
+2
+0.5% +$1.14K ﹤0.01% 924
2025
Q3
$208K Buy
+404
New +$176K ﹤0.01% 926
2024
Q3
– Sell
-1,355
Closed -$558K – 945
2024
Q2
$558K Sell
1,355
-417
-24% -$165K 0.02% 506
2024
Q1
$716K Sell
1,772
-606
-25% -$213K 0.02% 422
2023
Q4
$729K Sell
2,378
-3
-0.1% -$810 0.02% 383
2023
Q3
$577K Buy
2,381
+3
+0.1% +$767 0.02% 414
2023
Q2
$571K Buy
2,378
+742
+45% +$154K 0.02% 421
2023
Q1
$308K Buy
1,636
+536
+49% +$111K 0.01% 609
2022
Q4
$234K Buy
+1,100
New +$220K 0.01% 680

Other funds holding MEDP

Diversified Trust's MEDP Position: Q3 2026 in Review

Diversified Trust opened a new position in Medpace (MEDP) in Q3 2026: 370 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #933 among its holdings. This is a return to the name: Diversified Trust previously reported a position in MEDP as recently as Q4 2025.

Diversified Trust first reported a position in MEDP in Q4 2022 and has held it in 10 quarters since. The position peaked at $729K in Q4 2023. 405 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Diversified Trust held 370 shares of Medpace worth $231K as of Q3 2026.
  • Medpace was a new Diversified Trust position in Q3 2026.
  • Medpace made up ﹤0.01% of Diversified Trust's portfolio in Q3 2026, its #933 holding.
  • Diversified Trust first reported a position in Medpace in Q4 2022 and has held it in 10 quarters since.
  • Diversified Trust's Medpace position peaked at $729K in Q4 2023.
  • 405 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Diversified Trust's 13F filing for Q3 2026, filed 6 Nov 2026.